| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 0.4 | 0.5 |
| Gross profit | 0.4 | 0.5 |
| Profit before tax | 0.0 | 0.0 |
| Net income | 0.0 | 0.0 |
| EPS (diluted, $ a share) | $-0.00 | $-0.00 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | -85.0% |
|---|---|
| Revenue, year on year | -19.2% |
| Gross margin | 85.1% |
| Operating margin | 6.6% |
10-Q filed with the SEC, OTC: VYCO. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Vycor Medical Inc: key numbers
- Share price
- $0.0440Close, Nov 13
- Market cap
- $1.47M
- Shares outstanding
- 33.37MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Vycor Medical Inc
All →Vycor Medical Financial Results
Vycor Medical reported Q3 2026 revenue of $0.41M, a 19% decrease year-over-year, primarily due to higher-than-normal bulk orders in the prior year period. Despite the revenue decline, the company maintained a high gross margin of 85% and reported a nine-month operating profit of $80,083.
- Term
- Q3 2026